"Drug Repurposing to Identify Nilotinib as a Potential SARS-CoV-2 Main ..."

Souvik Banerjee et al. (2021)

> Home

Details and statistics

DOI: 10.1021/ACS.JCIM.1C00524

access: closed

type: Journal Article

metadata version: 2024-08-04

- view
  - electronic edition via DOI
  - unpaywalled version
  authority control:
- export record
  dblp key:
  - journals/jcisd/BanerjeeYBFPRSM21
- ask others
- share record
  persistent URL:
  - https://dblp.org/rec/journals/jcisd/BanerjeeYBFPRSM21
Souvik Banerjee, Shalini Yadav, Sourav Banerjee, Sayo O. Fakayode, Jyothi Parvathareddy, Walter Reichard, Surekha Surendranathan, Foyez Mahmud, Ryan Whatcott, Joshua Thammathong, Bernd Meibohm, Duane D. Miller, Colleen B. Jonsson, Kshatresh Dutta Dubey:
Drug Repurposing to Identify Nilotinib as a Potential SARS-CoV-2 Main Protease Inhibitor: Insights from a Computational and In Vitro Study. J. Chem. Inf. Model. 61(11): 5469-5483 (2021)

manage site settings

To protect your privacy, all features that rely on external API calls from your browser are turned off by default. You need to opt-in for them to become active. All settings here will be stored as cookies with your web browser. For more information see our F.A.Q.